Related Articles
PBX1 is a valuable prognostic biomarker for patients with breast cancer
Status and prognostic value of immunological biomarkers of breast cancer
Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction
Sperm‑associated antigen 5 is a potential biomarker for poor prognosis in breast cancer
Expression and amplification of cyclin D1 in primary breast carcinomas: Relationship with histopathological types and clinico-pathological parameters